February 13, 2018 / 9:01 AM / 6 months ago

BRIEF-Staidson Beijing BioPharmaceuticals sees FY 2018 Q1 net profit down 10 pct to 25 pct

Feb 13(Reuters) - Staidson Beijing BioPharmaceuticals Co Ltd

* Sees FY 2018 Q1 net profit to decrease by 10 percent to 25 percent, or to be about 51 million yuan to 61.3 million yuan

* Says FY 2017 Q1 net profit was 68.1 million yuan

Source text in Chinese: goo.gl/Zqk8ck

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below